The Department of Endocrinology, 
The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults.
- Department of Endocrinology, Post Graduate Institute Of Medical Education and Research, Chandigarh, 160012, India. bhadadask@rediffmail.com.
- Department of Endocrinology, Parmanand Deepchand Hinduja Hospital, Mumbai, 400016, India.
- Endocrinology and Diabetology Division, Voluntary Health Services Hospital, Chennai, 600020, India.
- Department of Endocrinology, Post Graduate Institute Of Medical Education and Research, Chandigarh, 160012, India.
- Department of Endocrinology, Christian Medical College, Vellore, 632002, India.
- Department of Endocrinology, All India Institute Of Medical Sciences, New Delhi, 110023, India.
- Endocrinology Division, Bhaktivedanta Hospital, Thane, 401107, India.
- Endocrinology and Diabetes Division, Door to Care, Gurgaon, 122018, India.
- Department of Endocrinology, Dr. Ram Manohar Lohia Hospital, New Delhi, 110001, India.
- Department of Endocrinology, All India Institute Of Medical Sciences, Jodhpur, 342001, India.
- Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India.
- Department of Endocrinology, Army Hospital Research & Referral, New Delhi, 110010, India.
- Endocrinology Division, Sri Ramachandra Medical Center, Chennai, 600116, India.
- Department of Endocrinology, Institute of Post-Graduate Medical Education and Research, Kolkata, 700020, India.
- Department of Medicine, University of Illinois, Chicago, IL, 60612, USA.
- Department of Internal Medicine, Division of Endocrinology, Diabetes and Bone & Mineral Disorders, Henry Ford, Health System, Detroit, MI, 48202, USA.
- Endocrinology and Diabetes Division, Max Healthcare, New Delhi, 110017, India. ambrishmithal@hotmail.com.
Archives of osteoporosis Vol. 16 · Issue 1 · pp. 102
PMID 34176015 DOI 10.1007/s11657-021-00954-1
Cite This Article
Sanjay K Bhadada, Manoj Chadha, Usha Sriram, Rimesh Pal, Thomas V Paul, Rajesh Khadgawat, Ameya Joshi, Beena Bansal, Nitin Kapoor, Anshita Aggarwal, Mahendra K Garg, Nikhil Tandon, Sushil Gupta, Narendra Kotwal, Shriraam Mahadevan, Satinath Mukhopadhyay, Soham Mukherjee, Subhash C Kukreja, Sudhaker D Rao, Ambrish Mithal. The Indian Society for Bone and Mineral Research (ISBMR) position statement for the diagnosis and treatment of osteoporosis in adults. Archives of osteoporosis. 2021;16(1):102. doi:10.1007/s11657-021-00954-1
Abstract
UNLABELLED: The Indian Society for Bone and Mineral Research (ISBMR) has herein drafted clinical practice guidelines for the diagnosis and management of osteoporosis for the people of India. Implementation of the position statement in clinical practice is expected to improve the overall care of patients with osteoporosis in India.
PURPOSE: In India, osteoporosis is a major public health problem. However, in the absence of any robust regional guidelines, the screening, treatment, and follow-up of patients with osteoporosis are lagging behind in the country.
METHODS: The Indian Society for Bone and Mineral Research (ISBMR), which is a multidisciplinary group of physicians, researchers, dietitians, and epidemiologists and who study bone and related tissues, in their annual meeting, drafted the guidelines for the diagnosis and management of osteoporosis that would be appropriate in a resource constraint setting like India.
RESULTS: Diagnosis of osteoporosis can be made in a patient with minimal trauma fracture without the aid of any other diagnostic tools. In others, bone mineral density measured by dual-energy X-ray absorptiometry remains the modality of choice. Data indicates that osteoporotic fractures occur at an earlier age in Indians than in the West; hence, screening for osteoporosis should begin at an earlier age. FRAX can be used for fracture risk estimation; however, it may underestimate the risk of future fractures in our population and still needs validation. Maintaining optimum serum 25-hydroxyvitamin D levels is essential, which, in most cases, would require regular vitamin D supplementation. Pharmacotherapy should be guided by the presence/absence of vertebral/hip fractures or the severity of risk based on clinical factors, although bisphosphonates remain the first choice in most cases. Regular follow-up is essential to ensure adherence and response to therapy.
CONCLUSIONS: Implementation of the position statement in clinical practice is expected to improve the overall care of patients with osteoporosis in India.
Keywords
- Fracture prevention
- Guidelines
- ISBMR
- India
- Osteoporosis
